select ad.sno,ad.journal,ad.title,ad.author_names,ad.abstract,ad.abstractlink,j.j_name,vi.* from articles_data ad left join journals j on j.journal=ad.journal left join vol_issues vi on vi.issue_id_en=ad.issue_id where ad.sno_en='96631' and ad.lang_id='6' and j.lang_id='6' and vi.lang_id='6' In Vitro Potency of Combinatorial Antifungal Drugs towards C | 96631
真菌のゲノミクスと生物学

真菌のゲノミクスと生物学
オープンアクセス

ISSN: 2165-8056

概要

In Vitro Potency of Combinatorial Antifungal Drugs towards Candida Isolates from Patients

Sakshi Agarwal, Smitanjali Parida, Bhuvnesvri Jadoun, Shreya N Patel, Sumit Moolchandani, Himanshu Puniyani, Raviranjan Kumar Pandey, Mandvi Mathur, Sandeep K Shrivastava, Aakanksha Kalra*

Candidiasis is a fungal infection (mycosis) caused by an opportunistic yeast with only 8-10 pathogenic species. In spite of the multiple classes of antifungal drugs available to combat these infections, the treatment is hampered by drug toxicity, tolerability, emergence of drug resistant isolates and many more. Combination therapy has been suggested as a possible approach to improve these treatment outcomes. This study is, therefore, aimed at the analysis of the sensitivity of Candida isolates obtained from patients towards different classes of drugs affecting multiple pathways in the pathogen life cycle. Four different individual drugs with different mechanisms of action and six different combinations of these drugs at three different proportions (1:1, 1:3, and 3:1) were used for the study. All the drug sensitivity assays were performed by the agar well diffusion method. The results were statistically analyzed using Prism software. Results have shown synergistic effects of drug combinations on the sensitivity of the isolates without much variation in the stoichiometric ratios, thereby providing an alternative to monotherapy to combat the emergence of drug resistant isolates and drying existing drug pipelines.

免責事項: この要約は人工知能ツールを使用して翻訳されたものであり、まだレビューまたは検証されていません。
Top